Kallum Titchmarsh
Stock Analyst at Morgan Stanley
(n/a)
# 4,911
Out of 5,141 analysts
21
Total ratings
n/a
Success rate
-35.47%
Average return
Main Sectors:
Stocks Rated by Kallum Titchmarsh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MTD Mettler-Toledo International | Maintains: Equal-Weight | $1,550 → $1,475 | $1,377.55 | +7.07% | 2 | Feb 10, 2026 | |
| WST West Pharmaceutical Services | Initiates: Equal-Weight | $285 | $241.12 | +18.20% | 1 | Dec 2, 2025 | |
| WAT Waters | Initiates: Equal-Weight | $423 | $333.33 | +26.90% | 1 | Dec 2, 2025 | |
| INSP Inspire Medical Systems | Downgrades: Equal-Weight | $105 → $130 | $59.53 | +118.38% | 7 | Dec 2, 2025 | |
| DHR Danaher | Initiates: Overweight | $270 | $209.50 | +28.88% | 1 | Dec 2, 2025 | |
| A Agilent Technologies | Initiates: Overweight | $180 | $122.90 | +46.46% | 1 | Dec 2, 2025 | |
| PEN Penumbra | Maintains: Equal-Weight | $260 → $266 | $339.36 | -21.62% | 8 | Jul 31, 2025 |
Mettler-Toledo International
Feb 10, 2026
Maintains: Equal-Weight
Price Target: $1,550 → $1,475
Current: $1,377.55
Upside: +7.07%
West Pharmaceutical Services
Dec 2, 2025
Initiates: Equal-Weight
Price Target: $285
Current: $241.12
Upside: +18.20%
Waters
Dec 2, 2025
Initiates: Equal-Weight
Price Target: $423
Current: $333.33
Upside: +26.90%
Inspire Medical Systems
Dec 2, 2025
Downgrades: Equal-Weight
Price Target: $105 → $130
Current: $59.53
Upside: +118.38%
Danaher
Dec 2, 2025
Initiates: Overweight
Price Target: $270
Current: $209.50
Upside: +28.88%
Agilent Technologies
Dec 2, 2025
Initiates: Overweight
Price Target: $180
Current: $122.90
Upside: +46.46%
Penumbra
Jul 31, 2025
Maintains: Equal-Weight
Price Target: $260 → $266
Current: $339.36
Upside: -21.62%